1. Home
  2. NOM vs BOLD Comparison

NOM vs BOLD Comparison

Compare NOM & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Missouri Quality Municipal Income Fund

NOM

Nuveen Missouri Quality Municipal Income Fund

HOLD

Current Price

$11.35

Market Cap

26.3M

Sector

Finance

ML Signal

HOLD

Logo Boundless Bio Inc.

BOLD

Boundless Bio Inc.

HOLD

Current Price

$1.31

Market Cap

26.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOM
BOLD
Founded
1993
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
26.3M
26.9M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
NOM
BOLD
Price
$11.35
$1.31
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.00
AVG Volume (30 Days)
6.9K
125.4K
Earning Date
01-01-0001
11-05-2025
Dividend Yield
3.39%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.52
$1.00
52 Week High
$10.48
$2.77

Technical Indicators

Market Signals
Indicator
NOM
BOLD
Relative Strength Index (RSI) 43.57 63.57
Support Level $11.00 $1.14
Resistance Level $12.00 $1.24
Average True Range (ATR) 0.39 0.07
MACD -0.06 0.01
Stochastic Oscillator 21.85 76.24

Price Performance

Historical Comparison
NOM
BOLD

About NOM Nuveen Missouri Quality Municipal Income Fund

Nuveen Missouri Quality Municipal Income Fund is a diversified, closed-end management investment company operating in the United States. The Fund's investment objective is current income exempt from both regular federal income taxes and Missouri personal income taxes, and to enhance portfolio value relative to the Missouri municipal bond market by investing in tax-exempt Missouri municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued. The fund invests in municipal securities as well as floating rate securities, and derivatives such as futures, options, and swap contracts to the necessary extent.

About BOLD Boundless Bio Inc.

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: